Publication | Open Access
Dexamethasone Intravitreal Implant as Adjunctive Therapy to Ranibizumab in Neovascular Age-Related Macular Degeneration: A Multicenter Randomized Controlled Trial
42
Citations
35
References
2015
Year
DEX reduced the need for adjunctive ranibizumab treatment and showed acceptable tolerability in nvAMD patients.
| Year | Citations | |
|---|---|---|
Page 1
Page 1